Min, Ji Hye
Kim, Jong Man
Kim, Young Kon http://orcid.org/0000-0002-3070-4880
Kim, Honsoul
Choi, Gyu Seong
Kang, Tae Wook
Cha, Dongik
Hwang, Jeong Ah
Ko, Seong Eun
Ahn, Soohyun
Article History
Received: 15 September 2020
Revised: 12 November 2020
Accepted: 7 June 2021
First Online: 4 August 2021
Declarations
:
: The scientific guarantor of this publication is Young Kon Kim in the Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One (Soohyun Ahn, PhD) of the authors has significant statistical expertise.
: Written informed consent was obtained from each patient before enrollment.
: Institutional Review Board approval was obtained.
: Among the 198 patients, 91 (46.0%) and 122 (61.6%) have been previously reported in the prior reports from our institution. Previous studies focused on the comparison of the diagnostic performance of ECA-MRI and HBA-MRI based on LI-RADS v2017 (<i>Hepatology.</i> 2018 Dec;68(6):<i>2254-2266</i>), or the diagnostic performance of CT, ECA-MRI, and HBA-MRI alone, and in combination (<i>Clin Gastroenterol Hepatol</i> 2020 Aug;18(9):2091-2100). Our current study focused on the targetoid features and LR-M category of LI-RADS v2018 on each MRI. We defined a modified LR-5 category, which emphasizes enhancing capsule over targetoid features.
: • prospective• Diagnostic study• performed at one institution